**Question:** Which drug can be eliminated by nonenzymatic degradation?

---

**Core Concept:** Nonenzymatic degradation is a process by which drugs are broken down and eliminated from the body without the involvement of specific enzymes. This process can occur through chemical reactions such as hydrolysis, oxidation, or reduction.

**Why the Correct Answer is Right:** The correct answer, **D. Enalapril**, is eliminated through nonenzymatic degradation. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and heart failure. It is primarily eliminated through nonenzymatic hydrolysis, specifically by the carboxypeptidase A enzyme. This process breaks down enalapril into its active form, enalaprilat, which is responsible for its therapeutic effects.

**Why Each Wrong Option is Incorrect:**

A. **Salicylic Acid (Aspirin)** is eliminated through both enzymatic (by COX enzymes) and nonenzymatic processes (oxidation and hydrolysis). It is not exclusively eliminated by nonenzymatic degradation.

B. **Amiodarone** follows a complex pathway involving enzymatic and nonenzymatic processes (hydrolysis, oxidation, and reduction). It is not a drug eliminated solely via nonenzymatic degradation.

C. **Tricyclic Antidepressants** (e.g., amitriptyline) are primarily eliminated through enzymatic pathways (CYP enzymes) and secondary nonenzymatic pathways (oxidation, hydrolysis, and reduction). They are not primarily eliminated by nonenzymatic degradation.

---

**Clinical Pearl:** Understanding the elimination pathways of drugs is crucial for predicting drug interactions, dosage adjustments, and potential adverse effects. Nonenzymatic degradation is a secondary process for many drugs, and understanding the primary elimination pathways (enzymatic) is essential. Nonenzymatic degradation is more significant for drugs like salicylic acid and amiodarone, which undergo multiple enzymatic and nonenzymatic processes during elimination.

**Correct Answer: D. Enalapril**

Enalapril, a drug used for the treatment of hypertension and heart failure, is primarily eliminated through nonenzymatic hydrolysis. This process is carried out by carboxypeptidase A enzyme, which cleaves the drug into its active form, enalaprilat, responsible for its therapeutic effects. Enalapril's nonenzymatic degradation is the primary elimination pathway, making it the correct answer.

---

**Clinical Application:** Nonenzymatic degradation is an essential concept in pharmacology, as it contributes to drug elimination and its overall pharmacokinetics. Understanding these pathways helps in predicting drug interactions, dosage adjustments, and potential adverse effects. In the case of enalapril, nonenzymatic hydrolysis is the primary elimination pathway, ensuring a thorough understanding of this concept is crucial for medical students and practitioners.